Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Devices using human tissue proposed for Class III status under EU device amendments.

This article was originally published in The Gray Sheet

Executive Summary

EU DIRECTIVE AMENDMENT WOULD PUT DEVICES USING HUMAN TISSUE IN CLASS III, the most stringent regulatory category under the European Union's medical device system. According to a proposal recently released by the Commission of the European Communities, the EU's Medical Device Directive (MDD) would be amended to so that "all devices manufactured utilizing human tissues or substances derived from such tissues are in Class III." The proposed amendments to the MDD directive -- the regulatory program for the vast majority of medical devices -- are noted in the latest version of the pending directive on in vitro medical devices.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT004103

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel